tiprankstipranks
CymaBay price target raised to $12 from $10 at H.C. Wainwright
The Fly

CymaBay price target raised to $12 from $10 at H.C. Wainwright

H.C. Wainwright analyst Ed Arce raised the firm’s price target on CymaBay to $12 from $10 and keeps a Buy rating on the shares. On yesterday’s earnings call, management focused on the breadth of clinical and real-world data on seladelpar in the treatment of primary biliary cholangitis, the analyst tells investors in a research note. The firm continues to have "high confidence" in seladelpar, especially based on ENHANCE data.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on CBAY:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles